Late-Onset Neutropenia After Rituximab in Multiple Sclerosis: Incidence, Predictors, and Outcomes in a Retrospective Multicenter Cohort.

Rituxan (rituximab) - Roche

Tysabri (natalizumab) - Biogen, Royalty

http://www.ncbi.nlm.nih.gov/pubmed/42743451

Anders Svenningsson; Björn Evertsson; Jan Lycke; Jonatan Salzer; Katharina Fink; Malin Boremalm; Pierre de Flon; Sandra Kallin; Susanna Hallberg

Sep 16, 2026